Business ❯ Law

Securities

Class Action Litigation Class Action Lawsuits Securities Fraud Class Action Lawsuit Misleading Statements

Atara Investors Face May 22 Deadline In Class Action Over FDA Setbacks

The filings argue that hidden manufacturing lapses, alongside trial flaws, derailed FDA approval.

Stories older than 24h

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

Picard Medical Investors Face Conflicting Deadlines as Class Action Moves Toward Lead‑Plaintiff Fight

Navan IPO Investors Urged to Seek Lead-Plaintiff Role as April 24 Deadline Nears

CoreWeave Securities Lawsuit Enters Lead‑Plaintiff Phase Ahead of March 13 Deadline

BellRing Faces Securities Class Action in SDNY Over Alleged Misstatements on Demand

Coupang Investors Face Feb. 17 Lead‑Plaintiff Deadline in Data‑Breach Securities Fight

Ardent Health Investors Press Securities Case as Firms Seek Lead Plaintiff by March 9

Sprouts Investors Face Jan. 26 Deadline to Seek Lead Role in Securities Class Action

Varonis Investors Face March 9 Lead Plaintiff Deadline in Securities Class Action

Coupang Hit With New Investor Suits as Class Period Expands in Data-Breach Case

Law Firms Seek Sprouts Investors as Jan. 26 Lead‑Plaintiff Deadline Nears

Law Firms Press Stride Investors to Lead Securities Case Alleging ‘Ghost Students,’ Tech Failure

Inspire Medical Investors Press Class Action Over Inspire V Rollout With Lead-Plaintiff Deadline Jan. 5

Alto Neuroscience Investors Urged to Seek Lead Plaintiff Status by Sept. 19